Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples